Search Results - "Enright TL"

Biomimetic nanoparticles coated with ScFv-modified macrophage membranes for siRNA delivery to relieve brain metastases of lung cancer.

Authors: Lu, Yuan Qiao, Yan Wu, Ting et al.

Source: BMC Biotechnology. 9/2/2025, Vol. 25 Issue 1, p1-11. 11p.

Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung Cancer.

Authors: Zhang, Xuebing Zhang, Xia Yin, Hang et al.

Source: OncoTargets & Therapy. Jan2025, Vol. 18, p35-47. 13p.

Prognostic Significance of the Cachexia Index in Patients with Non-Small-Cell Lung Cancer and Brain Metastases after Stereotactic Radiotherapy.

Authors: Xu, Hui Zhang, Bin Zhang, Yongqian et al.

Source: Clinical Medicine Insights: Oncology. 3/3/2024, p1-9. 9p.

Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or metastasis: A systematic review and meta‐analysis.

Authors: Zeng, Yichun Zhang, Liying Liang, Yichen et al.

Source: Cancer Medicine. Jul2023, Vol. 12 Issue 13, p13928-13941. 14p.

Optimal sequencing of brain radiotherapy and immunotherapy for patients with non-small cell lung cancer and driver gene-negative, asymptomatic brain metastases.

Authors: Zhong W Wu S Zhu R et al.

Source: BMC cancer [BMC Cancer] 2026 Feb 15; Vol. 26 (1). Date of Electronic Publication: 2026 Feb 15.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

肺癌免疫检查点抑制剂联合放疗中国专家 共识 (2025版).

Alternate Title: Chinese expert consensus on the combination of immune checkpoint inhibitors and radiotherapy for lung cancer (2025 edition).

Source: Chinese Journal of Oncology. Jan2025, Vol. 47 Issue 1, p39-64. 26p.

Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1 inhibitors in patients with driver gene-negative non-small cell lung cancer brain metastases: a retrospective study.

Authors: Zhang, Xianwen Sun, Qian Chen, Rujun et al.

Source: BMC Cancer. 12/3/2024, Vol. 24 Issue 1, p1-13. 13p.

Patterns of failure after stereotactic radiosurgery for brain metastases from small cell lung cancer: outcomes in the immunotherapy era.

Authors: Marwaha AS Liang Y Shepard MJ et al.

Source: Journal of neuro-oncology [J Neurooncol] 2025 Mar; Vol. 172 (1), pp. 177-183. Date of Electronic Publication: 2024 Dec 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

Immunotherapy: an emerging modality to checkmate brain metastasis.

Authors: Ahmad, Aatiya Khan, Parvez Rehman, Asad Ur et al.

Source: Molecular Cancer. 7/15/2023, Vol. 22 Issue 1, p1-28. 28p.

非小细胞肺癌脑转移放疗联合免疫治疗的 研究进展.

Alternate Title: Progress of Research on Radiotherapy Combined with Immunotherapy for Brain Metastases from Non-small Cell Lung Cancer.

Authors: 孙逸初 梁飞 夏铀铀

Source: Cancer Research on Prevention & Treatment. Jul2023, Vol. 50 Issue 7, p705-709. 5p.

Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis.

Authors: Tian, Wentao Chu, Xianjing Tanzhu, Guilong et al.

Source: Journal of Translational Medicine. 4/5/2023, Vol. 21 Issue 1, p1-17. 17p.

Research progress of anti-angiogenic therapy combined with immunotherapy and radiotherapy for the treatment of brain metastases in non-small cell lung cancer (Review).

Authors: Li, Man Gao, Jingyan Lu, Fei et al.

Source: Oncology Letters. Sep2025, Vol. 30 Issue 3, pN.PAG-N.PAG. 1p.

Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic.

Authors: Rios-Hoyo A Arriola E

Source: Frontiers in immunology [Front Immunol] 2023 Oct 09; Vol. 14, pp. 1221097. Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases.

Authors: Yoo KH Park DJ Choi JH et al.

Source: Frontiers in oncology [Front Oncol] 2023 Aug 11; Vol. 13, pp. 1223599. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.

Authors: Yomo S Oda K Oguchi K

Source: Journal of neurosurgery [J Neurosurg] 2023 May 26; Vol. 139 (6), pp. 1628-1637. Date of Electronic Publication: 2023 May 26 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: American Association of Neurological Surgeons Country of Publication: United States NLM ID: 0253357 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1933-0693 (Electronic) Linking ISSN: 00223085 NLM ISO Abbreviation: J Neurosurg Subsets: MEDLINE

Efficacy and safety of combined immunotherapy and stereotactic radiosurgery in NSCLCBM patients and a novel prognostic nomogram: A real-world study.

Authors: Bashir S Wen L Zhang P et al.

Source: Frontiers in oncology [Front Oncol] 2023 Apr 14; Vol. 13, pp. 1068592. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis.

Authors: Xie M Su C

Source: Frontiers in oncology [Front Oncol] 2023 Jan 24; Vol. 12, pp. 1006284. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis.

Authors: Li S Chen K Yang M et al.

Source: Frontiers in immunology [Front Immunol] 2022 Sep 15; Vol. 13, pp. 991431. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study.

Authors: Gao X Chen M Liu X et al.

Source: Frontiers in oncology [Front Oncol] 2022 Apr 26; Vol. 12, pp. 879554. Date of Electronic Publication: 2022 Apr 26 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases.

Authors: Pierret T Giaj-Levra N Toffart AC et al.

Source: Frontiers in oncology [Front Oncol] 2022 Apr 12; Vol. 12, pp. 787080. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE